Zivo Bioscience, Inc. (OTC: ZIVO), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $4.27, +0.0%, on 2026-08-28, with a market cap of $17M as of 2026-08-26 and a net margin of -8513.4%. Institutional ownership, earnings history and filed financials are on the tabs below.
% of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
| # | Holder | Shares | Value | % of shares out | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CoreCap Advisors, LLC | 4,3604,360 | $29,430 | — | — |
| 2 | HUNTINGTON NATIONAL BANK | 104104 | $702 | — | — |
Ranked by each filer’s own reported value, not shares.
| Biggest buyers | Δ shares | Δ value | |
|---|---|---|---|
| No filer increased its position this quarter. | |||
| Biggest sellers | Δ shares | Δ value | |
|---|---|---|---|
| Kohmann Bosshard Financial Services, LLC | −500 | $3,375 | CLOSE |
Prior quarter split-rebased · 13Fs are long, US-listed only.
| Holder | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| CoreCap Advisors, LLC | — | — | 4K | 4K | 4K | 4K | $29,430 |
| HUNTINGTON NATIONAL BANK | — | — | 104 | 104 | 104 | 104 | $702 |
Green = added, red = trimmed, grey = held; a dash is a quarter with no 13F on file — a gap, not an exit.
Breaks = no 13F that quarter.
Short interest has its own tab now — open SI →
SEC Form 13F · ~10,250 filers, 10y · long-only, US-listed, filed ≤45d after quarter-end.
